Two giants of commercial gene research, Celera Genomics of Rockville,
Maryland, and Geron of Menlo Park, California, signed a deal this week to work
towards growing brand new organs from a patient’s own cells. Geron has a unique
supply of human stem cells, which can theoretically grow into particular sorts
of tissue, while sequencing heavyweight Celera will identify genes which control
tissue formation in embryos. “Our work under this alliance will bring us one
step closer to realising the therapeutic potential of human stem cells,” says
Thomas Okarma, Geron’s president.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
Ancient human DNA found on cave art for the first time
3
If you aren't terrified by this heatwave, you should be
4
Our verdict on The Selfish Gene: An unpopular piece of popular science
5
Europe鈥檚 heatwave is the hottest and most humid ever
6
How some people's brains make an extraordinary recovery from stroke
7
We鈥檝e uncovered a master gene that switches on human development
8
The race to understand how and when Thwaites glacier will collapse
9
You should turn off fans when it's too hot 鈥 but how hot is too hot?
10
Can home batteries help save the climate and save you money?
